More News

14 Dec 2018 Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO® (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
14 Dec 2018 Astellas Acquires Potenza Therapeutics
14 Dec 2018 deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples
14 Dec 2018 Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET™ Immunotherapy Drug Candidates
14 Dec 2018 Ridgeback Biotherapeutics LP announces licensing of mAb114, an experimental Ebola treatment, from the National Institute of Allergy and Infectious Diseases
14 Dec 2018 AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals
14 Dec 2018 Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School
14 Dec 2018 Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
14 Dec 2018 Lilly to Acquire Pre-Clinical Pain Program from Hydra Biosciences
13 Dec 2018 Merck and Instituto Butantan Announce Collaboration Agreement to Develop Vaccines to Protect Against Dengue Infections
12 Dec 2018 BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
12 Dec 2018 AC Immune and Lilly Announce License and Collaboration Agreement
12 Dec 2018 SHIONOGI and Ube Industries Entered into Strategic Research Collaboration for Novel Anti-RS Virus Drug Candidates
12 Dec 2018 Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
12 Dec 2018 GARDP, Eisai and Takeda announce partnership in the search for new antibiotics
11 Dec 2018 Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
11 Dec 2018 Avacta and LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance
11 Dec 2018 HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
11 Dec 2018 Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million
06 Dec 2018 XyloCor Therapeutics Raises $17 Million in Series A Financing to Advance Gene Therapy Portfolio in Cardiovascular Disease
06 Dec 2018 Casma Therapeutics Licenses Technology to Advance Autophagy-Based Drug Discovery
06 Dec 2018 4D Molecular Therapeutics Announces Collaboration to Advance Gene Therapies for Retinal Diseases with Oregon Health & Science University’s Casey Eye Institute and Oregon National Primate Research Center
06 Dec 2018 Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population
06 Dec 2018 Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data
05 Dec 2018 Icagen enters into Collaboration to Develop and Commercialize Therapy for Neurological Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up